The case against structured screening for Atrial Fibrillation in General Practice
|
|
- Estella Greene
- 5 years ago
- Views:
Transcription
1 The case against structured screening for Atrial Fibrillation in General Practice THE CASE AGAINST STRUCTURED SCREENING FOR ATRIAL FIBRILLATION IN GENERAL PRACTICE or the PCCJ conference Nov 2015 r Ivan Benett PwSI Cardiology, Clinical Director for Central Manchester CCG o Declarations of interest For the PCCJ conference Nov 2015 Dr Ivan Benett GPwSI Cardiology Clinical Director for Central Manchester CCG No Declarations of interest
2 I will argue that the greatest health gain is to anti-coagulate those who are already known to be at risk of stroke, rather than waste time screening for AF. Optimising treatment will save 12 strokes per year, each year, in Central Manchester. As opposed to 6 strokes in the first year if we adopt a screening strategy.
3 e.g. Smith WC, Lee AJ, Crombie IK, Tunstall- Pedoe H. Control of blood pressure in Scotland: the rule of halves. Br Med J 1990;300:981-3.
4 The study is part of the Rotterdam study, a population-based prospective cohort study among subjects aged 55 years and above. The prevalence at baseline was assessed in 6808 participants. Incidence of AF was investigated during a mean followup period of 6.9 years in 6432 persons. We identified 376 prevalent and 437 incident cases. Overall prevalence was 5.5%, rising from 0.7% in the age group years to 17.8% in those aged 85 years and above. The overall incidence rate was 9.9/1000 person years. The incidence rate in the age group years was 1.1/1000 person years, rose to 20.7/1000 person years in the age group years and stabilized in those aged 85 years and above. Prevalence and incidence were higher in men than in women. The lifetime risk to develop AF at the age of 55 years was 23.8% in men and 22.2% in women. Warfarin prevents 3 strokes per 100 patients with AF treated/yr *. *Sandercock P, et al. Atrial fibrillation and stroke. Prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project) BMJ 1997;314:1563-4
5 Is screening for AF effective? YES Cochrane review Systematic and opportunistic screening for AF increases the rate of detection of new cases compared with routine practice. While both approaches have a comparable effect on the overall AF diagnosis rate, the cost of systematic screening is significantly more than that of opportunistic screening from the perspective of the health service provider Moran PS et al., Cochrane Database Syst Rev Apr 30;4:CD doi: / CD pub2. Effectiveness of systematic screening for the detection of atrial fibrillation.
6 Question: How effective is screening for AF? Answer: An extra 2 cases for every 300 people over 65yrs screened in one (first) year. Fitzmaurice DA et al., Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial BMJ Aug 25; 335(7616): 383
7 BUT Many primary care professionals cannot accurately detect AF on an ECG, and interpretative software is not sufficiently accurate to circumvent this problem, even when combined with interpretation by a general practitioner. Diagnosis of atrial fibrillation in the community needs to factor in the reading of electrocardiograms by appropriately trained people.. Mant J et al., Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial BMJ Aug 25; 335(7616): 380
8 Screening was ineffective if performed at annual flu clinics. ECG immediately after pulse assessment is essential. Screening was acceptable to patients but required additional resources. Rhys GC et al., Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice. Qual Prim Care. 2013;21(2):
9 Do the benefits out-weight the costs? Benefits About 150/1,000 > 65 yrs One case/150 >65 yrs detected each year One case /1,000 registered population per year Central Manchester population c220, new cases assume nearly all at risk of stroke 6 extra strokes saved in the 1st year in Central Manchester (3/100/yr saved) Costs Monitoring Cost of drugs Adverse effects Opportunity costs
10 Prevalence of known AF in Central Manchester 5% prevalence of AF in over 65yr olds & 10% in over 75yr olds 1,2,3 In Central Manchester there are 15,000 people over 65 yrs 7% of the population No. of people on GP registers 1,500 = Prevalence 10% in > 65s 1. Hobbs FD, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost- effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005; 9: iii iv, ix x, Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: Fuster V, Ryden LE, Cannom DS, et al ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123(10): e
11 How many more people will we need to anticoagulate using CHA2DS2vasc? A real life study in British Primary Care Edge et al., PCCJ on-line April 2015 In a study of 9 practices (42,000) 395 had known AF 20 had CHA2DS2VASc = 0 30 had CHA2DS2VASc = 1
12 The proportion of people at risk of stroke according to risk score tool used Breakdown of Stroke Risk according to CHADS2 Breakdown of Stroke Risk according to CHA2DS2-VASc 12% 5% 8% 65% 23% 87% CHA2DS2-VASc = 0 CHA2DS2-VASc = 1 CHADS2 = 0 CHADS2 = 1 CHADS2 > 1 CHA2DS2-VASc > 1
13 Current stroke prevention (anticoagulation) treatment in highrisk groups categorised by both CHADS2 and CHA2DS2-VASc Stroke Risk Pts on anticoagulants Pts not on anticoagulants CHADS > patients 175 (68%) 80 (32%) CHA2DS2-VASc > patients 251 (72%) 94 (28%) Extrapolated to the whole of Central Manchester = about 420 people with known AF who are at risk but not anti-coagulated. Treating these will save 12 strokes per year, every year
14 Priorities for identification and treatment of Atrial Fibrillation 1. Stroke risk assessment and anti-coagulation of people with known AF 2. Treat symptoms of people with known AF 3. Diagnose people early by opportunistic screening
15 Summary It is important to identify new people with AF In a cash & workforce limited environment we need to prioritise The largest health gain is likely to be in properly assessing stroke risk, and managing that risk Identifying/case finding should remain as it is
AF Stroke Prevention Through Screening, Intervention and Patient Choice
AF Stroke Prevention Through Screening, Intervention and Patient Choice Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GP Partner Westcliffe Medical Group Trustee AF Association Trustee
More informationOptimising detection and stroke prevention strategies in patients with Atrial Fibrillation in West Hampshire
Optimising detection and stroke prevention strategies in patients with Atrial Fibrillation in West Hampshire Dr Chris Arden GP, Chandlers Ford GPSI Cardiology, Southampton West Hampshire CCG Cardiovascular
More informationGRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012
GRASP-AF- The National Picture Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012 Outline AF and stroke Objective Management of stroke risk Stroke risk
More informationTackling atrial fibrillation the health economics evidence
Tackling atrial fibrillation the health economics evidence Professor Gary Ford,CBE Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals
More informationAHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke. Version: 13 March 2017
AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke Version: 13 March 2017 Introduction This business case template has been created so that
More informationCosting Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)
Putting NICE guidance into practice Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180) Published: June 2014 This costing report accompanies the clinical
More informationProfessor DA Fitzmaurice Primary Care Clinical Sciences University of Birmingham
New Guidelines for SPAF Professor DA Fitzmaurice Primary Care Clinical Sciences University of Birmingham Stroke prevention and atrial fibrillation Epidemiology of atrial fibrillation How common is it?
More informationOptimising detection and stroke prevention strategies in patients with Atrial Fibrillation in West Hampshire
Optimising detection and stroke prevention strategies in patients with Atrial Fibrillation in West Hampshire Dr Chris Arden GP, Chandlers Ford GPSI Cardiology, Southampton West Hampshire CCG Cardiovascular
More informationAtrial Fibrillation Detection in the Community and Hospital settings
Atrial Fibrillation Detection in the Community and Hospital settings Shuja Punekar Consultant Cerebrovascular Physician Hon Senior Lecturer, Manchester Medical School How common is AF in the population
More informationAtrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency
Atrial Fibrillation A guide for Southwark General Practice Key Messages 1. Routinely offer pulse checks to patients at high risk of AF 2. Use the CHA 2 DS 2 VASc score to identify patients for anticoagulation
More informationAtrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie
Atrial Fibrillation Implementation challenges Lesley Edgar Ross Maconachie Atrial Fibrillation Most common heart rhythm disturbance Rapid and irregular electrical signals Reduced efficiency of blood flow
More informationThat the Single Commissioning Board supports the project outlined in this report and proceeds as described.
Report to: SINGLE COMMISSIONING BOARD Date: 26 September 2017 Officer of Single Commissioning Board Subject: Report Summary: Recommendations: Jessica Williams Interim Director of Commissioning ATRIAL FIBRILLATION
More informationConsensus document: Screening and Prevention of Atrial Fibrillation
Consensus document: Screening and Prevention of Atrial Fibrillation Yong-Seog Oh, M.D.,Ph.D. Division of Cardiology, Department of Internal Medicine, Seoul St. Mary s Hospital, College of Medicine, The
More informationManagement of Atrial Fibrillation in Primary Care
Cardiac and Stroke Networks in Lancashire & Cumbria Lancaster Morecambe Carnforth and Garstang PBC North Lancashire Teaching PCT Management of Atrial Fibrillation in Primary Care Jeannie Hayhurst, CSNLC
More informationAudit+ Atrial Fibrillation Module (beta V2.1) quick start guide To Review Therapy
Save A Stroke Campaign 2016 Quality Improvement Cardiff & Vale UHB & Public Health Wales Audit+ Atrial Fibrillation Module (beta V2.1) quick start guide To Review Therapy 1 Quality Improvement [AUDIT+
More informationDOACs for Atrial Fibrillation, Why Are So Many AF Patients NOT on Anticoagulation? David Garcia, MD April 2017
DOACs for Atrial Fibrillation, Why Are So Many AF Patients NOT on Anticoagulation? David Garcia, MD April 2017 Disclosures for David Garcia Consultancy: Boehringer Ingelheim; Bristol-Meyers Squibb; Daiichi
More informationPrevalence (%) Table S4 Prevalence of AF in women and men, age- specific Study name/country Study population Study period Age group
Table S4 Prevalence of AF in and men, age- specific Study name/country Yunnan Province, China Random sample of government Guo (2015) 1 medical insurance plan Age 20 years Spain Gomez- Doblas (2014) 2 The
More informationReview of devices for early AF detection Nadya Hamedi Primary Care cardiovascular pharmacist Health innovation Network
Review of devices for early AF detection Nadya Hamedi Primary Care cardiovascular pharmacist Health innovation Network n.hamedi@nhs.net HRC 2016 The ICC Birmingham UK 9-12 October 2016 PAN London AF Improvement
More informationGLORIA -AF REGISTRY PROGRAMME
GLORIA -AF REGISTRY PROGRAMME EXECUTIVE SUMMARY The approval of novel oral anticoagulants has changed prescribing patterns for stroke prevention in atrial fibrillation (AF) worldwide. 1 There is a need
More informationRestart or stop antithrombotics after intracerebral haemorrhage (ICH)?
Restart or stop antithrombotics after intracerebral haemorrhage (ICH)? Rustam Al-Shahi Salman professor of clinical neurology & honorary consultant neurologist www.rush.ed.ac.uk @BleedingStroke /bleedingstroke
More informationDiagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation
(2009), 1 5 & 2009 Macmillan Publishers Limited All rights reserved 0950-9240/09 $32.00 www.nature.com/jhh ORIGINAL ARTICLE Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation
More informationAtrial fibrillation detection and management. Professor Lis Neubeck Head of Theme Long Term Conditions
Atrial fibrillation detection and management Professor Lis Neubeck Head of Theme Long Term Conditions Atrial fibrillation Most common cardiac arrhythmia Symptoms range from severely debilitating to none
More informationEvaluate Risk of Stroke & Bleeding in AF Patients
XV World Congress of Arrhythmias, Beijing, China - 17-20 September, 2015 Evaluate Risk of Stroke & Bleeding in AF Patients Antonio Raviele, MD, FESC, FHRS President ALFA Alliance to Fight Atrial fibrillation
More informationRESEARCH INTRODUCTION
1 Department of Primary Care and General Practice, University of Birmingham, Birmingham B15 2TT 2 Health Economics Facility, Health Services Management Centre, University of Birmingham, Birmingham B15
More informationAgenda Item No. 8a SERVICE SPECIFICATION. 1. Introduction:
SERVICE SPECIFICATION Agenda Item No. 8a Service Specification No. Service Atrial Fibrillation Audit patient reviews Commissioner Lead Caroline Davidson Period 1 st September to 31 st March 2017 Date of
More informationMEDICAL POLICY SUBJECT: HOME PROTHROMBIN TIME MONITORING DEVICE. POLICY NUMBER: CATEGORY: Equipment/Supplies
MEDICAL POLICY SUBJECT: HOME PROTHROMBIN TIME 06/23/16, 6/22/17 PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial
More informationADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE
ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE HELEN WILLIAMS FFRPS, MRPHARMS, PGDIP (CARDIOL) IPRESC CONSULTANT PHARMACIST FOR CVD, SOUTH LONDON CLINICAL LEAD FOR ATRIAL FIBRILLATION, HEALTH INNOVATION
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationNew Routes to Integrated Care: Smart-phones and and changing GP roles
New Routes to Integrated Care: Smart-phones and and changing GP roles Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner
More informationEffectiveness of systematic screening for the detection of atrial fibrillation.
Royal College of Surgeons in Ireland e-publications@rcsi General Practice Articles Department of General Practice 1-1-2013 Effectiveness of systematic screening for the detection of atrial fibrillation.
More informationPopulation Screening for AF is not Worthwhile. Jonathan P. Piccini, MD, MHS, FHRS Associate Professor of Medicine
Population Screening for AF is not Worthwhile Jonathan P. Piccini, MD, MHS, FHRS Associate Professor of Medicine Population Screening for AF is not Worthwhile Jonathan P. Piccini, MD, MHS, FHRS Associate
More informationAtrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology
Atrial Fibrillation Ivan Anderson, MD RIHVH Cardiology Outline Definition and Pathophysiology Rate versus rhythm control Rate control thresholds (how much is enough) Anti-coagulation CHADS2VASc score HASBLED
More informationL. Fauchier (1), S. Taillandier (1), I. Lagrenade (1), C. Pellegrin (1), L. Gorin (1), A. Bernard (1), B. Rauzy (1), D. Babuty (1), GYL.
Prognosis in patients with atrial fibrillation and CHA 2 DS 2 VASc score=0 in a real world community based cohort study: Loire Valley Atrial Fibrillation project L. Fauchier (1), S. Taillandier (1), I.
More informationTaggar, Jaspal (2017) Screening for atrial fibrillation in primary care. PhD thesis, University of Nottingham.
Taggar, Jaspal (2017) Screening for atrial fibrillation in primary care. PhD thesis, University of Nottingham. Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/44379/1/jaspal%20taggar%20phd%20write%20up
More informationStudy period Total sample size (% women) 899 (37.7%) Warfarin Aspirin
Table S2 Sex- specific differences in oral anticoagulant prescription for stroke prevention in AF Total sample size (% women) Anticoagulant(s) studied Gage (2000) 1 Missouri, USA Discharged during 597
More informationThe Size of the Prize Doing Things Differently To Prevent Heart Attacks and Strokes at Scale
The Size of the Prize Doing Things Differently To Prevent Heart Attacks and Strokes at Scale Dr Matt Kearney GP and National Clinical Director for Cardiovascular Disease Prevention NHS England and Public
More informationAtrial Fibrillation Key Messages
Atrial Fibrillation Key Messages Dr Matthew Fay Westcliffe Medical Practice National Clinical Lead NHS Improvement www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429 Clinical Events
More informationMohammad Zubaid, MB, ChB, FRCPC, FACC
Management and one year outcome of atrial fibrillation in Middle Eastern cohort enrolled in the observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Mohammad Zubaid, MB, ChB, FRCPC, FACC
More informationAtrial Fibrillation (AF)
Coronary Heart Disease Managed Clinical Network Atrial Fibrillation (AF) Guidelines for Primary Care Definition Atrial Fibrillation (AF) is defined as a cardiac arrhythmia with the following characteristics:
More informationAF Diagnosis. Incorporated into over 75 health checks and Public Health Checks
AF Diagnosis Incpated into over 75 health checks and Public Health Checks Pulse Feel the pulse in all >65yrs If irregular do a 12 Lead ECG with Rhythm strip Check Thyroid and FBC and heart rate Refer to
More informationUS FDA Approves Pradaxa (dabigatran etexilate) a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation
Press Release For non-us Healthcare Media Boehringer Ingelheim GmbH Corporate Communications US FDA Approves Pradaxa (dabigatran etexilate) a breakthrough treatment for stroke risk reduction in non-valvular
More informationStratificazione del rischio, corretto bilancio tra ischemia e bleeding: il beneficio clinico netto
Fibrillazione atriale: rischio tromboembolico, Venezia - 27/28 Novembre 2015 Stratificazione del rischio, corretto bilancio tra ischemia e bleeding: il beneficio clinico netto Antonio Raviele, MD, FESC,
More informationEpidemiology current status: heart and brain
Epidemiology current status: heart and brain Veikko Salomaa, MD, PhD Research Professor 22.5.2012 Heart and brain/ Veikko Salomaa 1 Veikko Salomaa, MD, PhD Research Professor National Institute for Health
More informationNeuroPI Case Study: Anticoagulant Therapy
Case: An 82-year-old man presents to the hospital following a transient episode of left visual field changes. His symptoms lasted 20 minutes and resolved spontaneously. He has a normal neurological examination
More informationInitial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care
Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care 11 th and 25 th September 2014 3 KEY OBJECTIVES OF TALK 1.
More informationAtrial Fibrillation and You
Atrial Fibrillation and You Dr Matthew Fay General Practitioner AFA Medical Advisory Committee Member NHS-Improvement Clinical Lead AF & U Dr Matthew Fay General Practitioner AFA Medical Advisory Committee
More informationSummative Assessment Audit Project. Project Number 02
Summative Assessment Audit Project Project Number 02 AUDIT TITLE: Aspirin and Warfarin prophylaxis of thromboembolism in elderly patients with Atrial Fibrillation. What is the title of your audit project?
More informationShow Me the Outcomes!
Show Me the Outcomes! Real-World Safety Data on Oral Anticoagulants in Nonvalvular Atrial Fibrillation Gabby Anderson, PharmD PGY1 Pharmacy Resident anderson.gabrielle@mayo.edu Pharmacy Grand Rounds October
More informationDr Mammen Ninan GPwSI in Cardiology
Dr Mammen Ninan GPwSI in Cardiology AF affects up to 835,000 people in England alone and is expected to rise year after year. AF is a known risk factor for stroke, the 3 rd highest cause of mortality in
More informationWhat are the risk factors for AF?
Susan Mayor was paid in her capacity as a medical writer for her time to research and write this article for Boehringer Ingelheim. This article has been reviewed by Boehringer Ingelheim to ensure compliance
More informationKCS Congress: Impact through collaboration
Stroke Prevention in Atrial Fibrillation (SPAF) in Kenya Elijah N. Ogola FACC University of Nairobi Kenya Cardiac Society Annual Scientific Congress Mombasa 28 th June 1 st July 2017 KCS Congress: Impact
More informationProf. Fiorenzo Gaita
Adavances in Cardiac Arrhythmias and Great Innovations in Cardiology Turin 2014 Can rhythm control strategy reduce the risk of clinical and silent cerebral ischemia? Prof. Fiorenzo Gaita Director of the
More informationNovel Anticoagulants: Emerging Evidence
18/10/2016 Topics: Novel Anticoagulants: Emerging Evidence Dr Matthew Swale Electrophysiologist Genesis Care NOAC Novel Oral Anti Coagulant Now Non-Vit K Oral Anti Coagulant DOAC Direct Oral Anti Coagulant
More informationModern management of atrial fibrillation, from blood pressure control to anticoagulation
Modern management of atrial fibrillation, from blood pressure control to anticoagulation Adel Khalifa S. Hamad, BMS, MD, FRCP(Canada) Consultant Cardiologist & Interventional Cardiac Electrophysiologist
More informationWarfarin Management-Review
Warfarin Management-Review December 18, 2012 Elaine M. Hylek, MD, MPH Director, Thrombosis Clinic and Anticoagulation Service Boston University Medical Center Areas for Discussion Implications of time
More informationBristol-Myers Squibb/Pfizer Alliance Independent Medical Education
Bristol-Myers Squibb/Pfizer Alliance Independent Medical Education Request for Educational Support (RFE) Date February 26, 2017 RFE Requestor Information RFE Code Therapeutic Area Area of Interest Name:
More informationDefining Sub-Clinical Atrial Fibrillation and its management
Defining Sub-Clinical Atrial Fibrillation and its management Jeff Healey MD, MSc, FRCP, FHRS PHRI Chair in Cardiology Research Population Health Research Institute McMaster University, Canada Sub-Clinical
More informationElectrocardiogram interpretation and arrhythmia management:
Research Gordon Begg, Kathryn Willan, Keith Tyndall, Chris Pepper and Muzahir Tayebjee Electrocardiogram interpretation and arrhythmia management: a primary and secondary care survey Abstract Background
More informationBristol-Myers Squibb/Pfizer Alliance Independent Medical Education
Bristol-Myers Squibb/fizer Alliance Independent Medical Education Request for Educational Support (RFE) Date October 5, 2017 RFE Requestor Information RFE Code Name: Sylvia Nashed, harmd, Rh Title: IME
More informationrequesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group
October 2015 Our Ref: FOI.15.ASH0149 requesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group Original Request Survey attached. Question 1: Between 1 July 2014 and
More informationקוים מנחים לפרפור פרוזדורים - עדכון משה סויסה מרכז רפואי קפלן
קוים מנחים לפרפור פרוזדורים - עדכון משה סויסה מרכז רפואי קפלן INTRODUCTION The prevalence of atrial fibrillation (AF) is approximately 1.5 2% of the general population The arrhythmia is associated: with
More informationΣτυλιανός Τζέης MD, PhD, FESC
Βραχειάς δια ρκειας ριπε ςυπερκοιλιακη ς ταχυαρρυθμιάς στο Holter ρυθμου η στις συσκευε ςδιαχει ρισης του καρδιακου ρυθμου. Θα χορηγη σουμε αντιθρομβωτικη αγωγη ; Στυλιανός Τζέης MD, PhD, FESC Επιμελητής
More informationIdentifying Patients for Anticoagulation: While Many Patients Remain Untreated, Who Should NOT be Anticoagulated?
Identifying Patients for Anticoagulation: While Many Patients Remain Untreated, Who Should NOT be Anticoagulated? Renato D. Lopes, MD MHS PhD Professor of Medicine Division of Cardiology Duke Clinical
More information18/09/2012. Dr. Khalid Khan Consultant Cardiologist BCUHB. Oral Anticoagulation Update Day 12 th September 2012 University of Birmingham
Dr. Khalid Khan Consultant Cardiologist BCUHB Oral Anticoagulation Update Day 12 th September 2012 University of Birmingham 1 NICE vs. Local Guidance NICE says no We say no NICE says yes We say no NOACs
More informationSecondary Preven-on of Thromboembolic Stroke: Clinical Data and Recommenda-ons from the ESC Atrial Fibrilla-on Guideline Update 2012
Secondary Preven-on of Thromboembolic Stroke: Clinical Data and Recommenda-ons from the ESC Atrial Fibrilla-on Guideline Update 2012 Professor Dan Atar Head, Dept. of Cardiology Councillor of the ESC,
More informationDr. Khalid Khan Consultant Cardiologist
Dr. Khalid Khan Consultant Cardiologist BCUHB (Wrexham) WCS Spring Meeting 2012 When the pulse is irregular and tremulous and the beats occur at intervals, then the impulse of life fades; when the pulse
More informationAsymptomatic Atrial Fibrillation: Detection and Management. 18 December nd Annual Advances in Heart Disease Palace Hotel, San Francisco
Asymptomatic Atrial Fibrillation: Detection and Management 18 December 2015 32 nd Annual Advances in Heart Disease Palace Hotel, San Francisco Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine
More informationAdverse prognosis of incidentally detected ambulatory atrial fibrillation
Blood Coagulation, Fibrinolysis and Cellular Haemostasis 276 Adverse prognosis of incidentally detected ambulatory atrial fibrillation A cohort study Carlos Martinez ; Anja Katholing ; Saul Benedict Freedman
More informationThe Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician
The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has
More informationPros and Cons of Individual Agents Based on Large Trial Results: RELY, ROCKET, ARISTOTLE, AVERROES
Pros and Cons of Individual Agents Based on Large Trial Results: RELY, ROCKET, ARISTOTLE, AVERROES Ralph L. Sacco, MS MD FAAN FAHA Olemberg Family Chair in Neurological Disorders Miller Professor of Neurology,
More informationNational Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation
Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation August 2008 This technology summary is based on information available at the time of
More informationAuthors Emma Tassie Graham Scotland Aileen R Neilson* *Corresponding Author
A model based cost-effectiveness analysis of opportunistic screening for identifying atrial fibrillation with a single lead handheld electrocardiogram monitor in general practices in Scotland Authors Emma
More informationQuestion 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG:
Atrial Fibrillation in Your Area Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG: a) What was the prevalence of atrial fibrillation (AF)? 6636 (as of 22/10/2015) 2.1%
More informationPrimary Care Atrial Fibrillation Update: Anticoagulation and Left Atrial Appendage Occlusion. Greg Francisco, MD, FACC
Primary Care Atrial Fibrillation Update: Anticoagulation and Left Atrial Appendage Occlusion Greg Francisco, MD, FACC DISCLOSURES None to declare Estimated 33.5million have AF worldwide (6-7million in
More informationAtrial Fibrillation & Acute Stroke
Atrial Fibrillation & Acute Stroke Acute Stroke Stroke Facts Aetiology Thrombosis Classification outcomes Time is Brain Acute Stroke Over 5 million people die as a result of stroke and another 5 million
More informationShould AF patients (after ablation) have anticoagulation forever? Can we ever stop it?
The 12 International Dead Sea Symposium - Jerusalem March 3-5 /2014 Should AF patients (after ablation) have anticoagulation forever? Can we ever stop it? Antonio Raviele, MD, FESC, FHRS Past Director
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation Thank you for agreeing to give us a statement on your organisation s view of the technology and the way
More informationResults from RE-LY and RELY-ABLE
Results from RE-LY and RELY-ABLE Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in longterm stroke prevention EXECUTIVE SUMMARY Dabigatran etexilate (Pradaxa ) has shown a consistent
More information1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?
1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? Dr Nerys Davies, GPST Ms B. Davies, Specialist Nurse (Heart Failure) Dr J. Taylor, Consultant Cardiologist
More informationRhona Maclean
An early evaluation of the impact of the North Trent policy regarding the use of Non-Vitamin K antagonists for SPAF in a secondary care anticoagulation clinic Rhona Maclean Rhona.maclean@sth.nhs.uk Risk
More informationAfib, Stroke, and DOAC. Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS
Afib, Stroke, and DOAC Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS Disclosure of Relevant Financial Relationships I have no relevant financial relationships with commercial
More informationScreening for atrial fibrillation with the WatchBP device as compared to current clinical practice: a cost-analysis.
Screening for atrial fibrillation with the WatchBP device as compared to current clinical practice: a cost-analysis. Introduction Atrial Fibrillation Atrial fibrillation (AF) is the most common cardiac
More informationQuality Improvement Tool Instruction Guide GRASP-AF
Quality Improvement Tool Instruction Guide GRASP-AF The GRASP-AF quality improvement tool has been developed by PRIMIS and delivered in partnership with NHS England. Prepared by PRIMIS September 2017 The
More informationConsequences of stroke and AF
Consequences of stroke and AF Lorenzo G Mantovani Center of Pharmacoeconomics University of Naples Center for Public Health Research University of Milan Bicocca Questions Is stroke frequent? Is stroke
More informationGetting Serious About CVD Prevention What does this mean for Primary Care?
Getting Serious About CVD Prevention What does this mean for Primary Care? Dr Matt Kearney GP and National Clinical Director for Cardiovascular Disease Prevention NHS England and Public Health England
More informationStroke Prevention & Atrial Fibrillation. Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015
Stroke Prevention & Atrial Fibrillation Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015 Learning Outcomes What is Atrial Fibrillation? Why is Atrial Fibrillation important? What causes
More informationSpontaneous Atrial Fibrillation and Noacs and Reversal agents
Spontaneous Atrial Fibrillation and Noacs and Reversal agents Laurent Lewkowiez, MD Regional Service Chief, Hospital Cardiology CPMG Cardiac Electrophysiology Educational Goals relationship between atrial
More informationA Case of Cerebral Infarction in Atrial Fibrillation Caused by Interruption of Warfarin Therapy for Colonoscopy
A Case of Cerebral Infarction in Atrial Fibrillation Caused by Interruption of Warfarin Therapy for Colonoscopy Sang-Jin, Han, MD Cardiology Division, Department of Internal Medicine, Hallym University
More informationExtrapolating from fit to frail. Is it possible? How to assess the efficacy of preventive strategies in older subjects
Extrapolating from fit to frail. Is it possible? How to assess the efficacy of preventive strategies in older subjects Antonio Cherubini IRCCS-INRCA, Italy CONFLICT OF INTEREST DISCLOSURE I have no potential
More informationLuisa Vinciguerra. Ictus recidivanti
Luisa Vinciguerra Ictus recidivanti Recurrent Strokes DEFINITION Population-based studies exclude strokes: - within 28 or 21 days of the incident event - events in the same vascular territory as the original
More informationDronedarone For Atrial Fibrillation: Unbridled Enthusiasm Or Just Another Small Step Forward?
Dronedarone For Atrial Fibrillation: Unbridled Enthusiasm Or Just Another Small Step Forward? James A. Reiffel, M.D. Introduction In July 2009, the federal Food and Drug Administration (FDA) approved the
More informationADC Slides for Presentation 02/10/2017
ADC 2017 Slides for Presentation ANTI THROMBOTIC THERAPY FOR NON VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: CURRENT VIEWS Martin A. Alpert, MD Brent M. Parker Professor of Medicine
More informationwww.stopastroke.co.uk Acknowledgements Rachel Rayment Graham Shortland Tristan Groves Sarah Holroyd Shakeel Ahmad Steve Gage Darrell Baker Fiona Walker Clare Evans Marilyn Rees Kay Jeynes Peter O Callaghan
More informationUK stroke incidence, mortality and cardiovascular risk management 1999e2008: time-trend analysis from the General Practice Research Database
Open Access To cite: Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999e2008: time-trend analysis from the General Practice Research Database. BMJ Open 2011;1:
More informationAtrial fibrillation: Who should be referred for ablation therapy for atrial fibrillation?. September 12 th, 2015
Atrial fibrillation: Who should be referred for ablation therapy for atrial fibrillation?. September 12 th, 2015 MMMMMMM MMMMMMM MMMMMMM Sohail Hassan MD FACC, FHRS Director, Cardiac Electrophysiology
More informationAtrial fibrillation and anticoagulation JIR-PING BOEY, DEPARTMENT OF HAEMATOLOGY, FLINDERS MEDICAL CENTRE FEBRUARY 2016
1 Atrial fibrillation and anticoagulation JIR-PING BOEY, DEPARTMENT OF HAEMATOLOGY, FLINDERS MEDICAL CENTRE FEBRUARY 2016 Disclosures 2 No conflicts of interest Some questions 3 Should my patient with
More informationAtrial Fibrillation Your quick guide
Atrial Fibrillation Your quick guide Coronary heart disease is the UK s single biggest killer. For over 50 years we ve pioneered research that s transformed the lives of people living with heart and circulatory
More information:{ic0fp'16. Geriatric Medicine: Optimal Heart Health Amid Changing Guidelines. (and the Evidence for When to Stray) Kevin Overbeck, DO
:{ic0fp'16 ACOFP 53 rd Annual Convention & Scientific Seminars Geriatric Medicine: Optimal Heart Health Amid Changing Guidelines (and the Evidence for When to Stray) Kevin Overbeck, DO Optimal Heart Health
More informationOAC after apparently successfull AF ablation: when, why, and how?
Gulf EP Live 2015 - Dubai January 22-24 / 2015 OAC after apparently successfull AF ablation: when, why, and how? Antonio Raviele, MD, FESC, FHRS Past Director Cardiovascular Department, dell Angelo Hospital,
More information